Numeta G19e

Valine, the active ingredient in Numeta G19e, is a nutrition supplement presented as a solution for intravenous use. It supports metabolic functions and amino acid balance in patients requiring parenteral nutrition. GNH USA supplies Numeta G19e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Numeta G19e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Numeta G19e is used in clinical nutrition to support patients who cannot receive oral intake. It is indicated for: - Post‑operative recovery: helps maintain protein synthesis and nitrogen balance. - Critical illness: provides essential amino acids for metabolic support. - Long‑term parenteral nutrition: sustains nutritional needs when enteral feeding is not possible. - Pre‑transplant conditioning: assists in maintaining nutritional status before transplantation. - Severe malnutrition: aids in restoring amino acid deficits.

Numeta G19e may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects: - Mild fever: transient elevation of body temperature during infusion. - Local irritation: redness or discomfort at the infusion site. - Nausea: occasional feeling of queasiness. - Headache: mild to moderate headache during or after infusion. - Electrolyte shift: minor changes in serum electrolytes. - Hyperglycemia: temporary rise in blood glucose levels.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Sepsis: infection related to catheter use. - Metabolic acidosis: significant acid‑base imbalance. - Hyperammonemia: elevated ammonia levels in blood. - Thrombophlebitis: inflammation of the vein with clot formation. - Renal impairment: worsening kidney function in susceptible patients.

When using Numeta G19e, clinicians should consider several safety measures.

- Monitor electrolytes: regular blood tests to detect imbalances. - Assess renal function: check kidney parameters before and during therapy. - Observe for infection: watch catheter sites for signs of infection. - Adjust glucose: manage blood sugar in diabetic patients. - Evaluate liver status: liver function tests are recommended. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Numeta G19e may interact with other intravenous solutions and medications.

Major Interactions (Avoid): - High‑dose potassium chloride: can cause dangerous electrolyte overload. - Acidic drug solutions: may precipitate amino acids, reducing efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may amplify electrolyte shifts. - Insulin therapy: increased risk of hypoglycemia when combined with glucose‑containing solutions. - Anticoagulants: potential alteration of coagulation parameters. - Other parenteral nutrition formulations: risk of nutrient excess. - Vasopressors: may affect peripheral circulation at infusion sites.